Radiant Biotherapeutics
Developer of a modular multi-valent and multi-specific platform intended to create antibodies for the treatment of cancer, inflammation, and infections. The company's platform offers multi-functional ...
Valuation
$0
Share Price
N/A
Total Raised
$43.1M
Last Round
N/A